Clinical Trials Directory

Trials / Completed

CompletedNCT06051864

Electrical Vestibular Nerve Stimulation (VeNS) As a Treatment for Depression

Effectiveness of Electrical Vestibular Nerve Stimulation in the Management of Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
62 (actual)
Sponsor
Neurovalens Ltd. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Trial title: Effectiveness of Electrical Vestibular Nerve Stimulation in the Management of Depression The aim of this study: To better evaluate the efficacy of non-invasive electrical vestibular nerve stimulation (VeNS) as a method of treating Depression, as compared to a sham control. Allocation: Randomized to either active device or control device usage. Endpoint classification: Efficacy Study Intervention Model: Parallel Assignment in 1:1 active to control allocation Sample size: The aim is to recruit a total of up to 60 participants. The study will last 12 weeks in total for each subject.

Detailed description

This double blind randomized controlled trial will enroll up to 60 subjects and will be conducted at the NRI Institute of Medical Sciences. The study will be randomized for a 8-week period with a 1:1 active to sham device allocation. Each participant will complete 5 stimulation sessions per week under the supervision of a researcher at the Department of Physiology. Each session will be 30 minutes on the day of usage. The scheduled study events are to be undertaken at the following timepoints: * Baseline: Study Visit 1 (0-week timepoint for enrolment) * Study Visit 2 (2-week timepoint) * Study Visit 3 (4-week timepoint) * Study Visit 4 (6-week timepoint) * End of Study: Study Visit 5 (8-week timepoint) * Post-intervention follow-up at 4 weeks (12-week timepoint)

Conditions

Interventions

TypeNameDescription
DEVICEModius Mood Active DeviceBattery powered non-invasive neurostimulation device
DEVICESham DevicePlacebo comparator sham device (no active stimulation)

Timeline

Start date
2023-12-03
Primary completion
2024-11-05
Completion
2024-11-05
First posted
2023-09-25
Last updated
2024-12-20

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT06051864. Inclusion in this directory is not an endorsement.